Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Repertoire Immune Medicines
Biotech
BMS pays $65M to expand Repertoire of autoimmune assets
The deal, which features up to $1.8 billion in future payments, covers tolerizing vaccines for up to three autoimmune diseases.
Nick Paul Taylor
Apr 29, 2024 6:15am
Flagship unveils Metaphore with $50M to mimic natural chemistry
May 16, 2023 6:00am
UPDATE: Flagship's Repertoire reveals culls, cuts and new CEO
Nov 7, 2022 10:47am
Repertoire nabs ex-Celgene exec as CMO—Chutes & Ladders
Jun 4, 2021 9:30am
Repertoire Immune Medicines nabs ex-Celgene exec as CMO
Jun 3, 2021 8:50am
Flagship's Repertoire allies with Yale on multiple sclerosis
Apr 29, 2021 8:55am
